INT222608

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.10
First Reported 2008
Last Reported 2009
Negated 0
Speculated 0
Reported most in Body
Documents 3
Total Number 3
Disease Relevance 0.29
Pain Relevance 0.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytoplasm (Acvr2a)
Acvr2a (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Action potential 7 69.88 Quite High
antagonist 78 5.00 Very Low Very Low Very Low
Nerve growth factor 56 5.00 Very Low Very Low Very Low
Inflammation 54 5.00 Very Low Very Low Very Low
cytokine 44 5.00 Very Low Very Low Very Low
agonist 44 5.00 Very Low Very Low Very Low
Calcitonin gene-related peptide 34 5.00 Very Low Very Low Very Low
substance P 32 5.00 Very Low Very Low Very Low
gABA 30 5.00 Very Low Very Low Very Low
Dopamine 26 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Targeted Disruption 65 99.70 Very High Very High Very High
Sunburn 1 55.64 Quite High
Repression 2 25.52 Quite Low
Stress 97 5.00 Very Low Very Low Very Low
INFLAMMATION 56 5.00 Very Low Very Low Very Low
Cancer 44 5.00 Very Low Very Low Very Low
Pituitary Cancer 22 5.00 Very Low Very Low Very Low
Starvation 20 5.00 Very Low Very Low Very Low
Rheumatoid Arthritis 16 5.00 Very Low Very Low Very Low
Natriuresis 14 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Similarly, in castrated mice in which the gene for activin receptor type II (Act-R-II) was disrupted, FSH?
Negative_regulation (disrupted) of Gene_expression (gene) of activin receptor type II
1) Confidence 0.10 Published 2008 Journal Journal of Neuroendocrinology Section Body Doc Link PMC2229370 Disease Relevance 0 Pain Relevance 0
Similarly, in castrated mice in which the gene for activin receptor type II (Act-R-II) was disrupted, FSH?
Negative_regulation (disrupted) of Gene_expression (gene) of Act-R-II
2) Confidence 0.10 Published 2008 Journal Journal of Neuroendocrinology Section Body Doc Link PMC2229370 Disease Relevance 0 Pain Relevance 0
In the present study, we established several lines of transgenic rats in which ChR2 expression was driven by the Thy-1.2 promoter.
Negative_regulation (driven) of Gene_expression (expression) of ChR2 associated with targeted disruption
3) Confidence 0.04 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2772120 Disease Relevance 0.29 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox